Literature DB >> 30262671

Proton Pump Inhibitors in Kidney Disease.

Benjamin Lazarus1,2, Morgan E Grams3,4.   

Abstract

Entities:  

Keywords:  Proton Pump Inhibitors; kidney disease

Mesh：

Substances：

Year:  2018        PMID： 30262671      PMCID： PMC6218826          DOI： 10.2215/CJN.10110818

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  11 in total

1.  Adverse outcomes of long-term use of proton pump inhibitors: a systematic review and meta-analysis.

Authors:  Md Mohaimenul Islam; Tahmina N Poly; Bruno A Walther; Navneet K Dubey; Dina N Anggraini Ningrum; Syed-Abdul Shabbir; Yu-Chuan Jack Li
Journal:  Eur J Gastroenterol Hepatol       Date:  2018-12       Impact factor: 2.566

2.  Effect of gastric acid suppression with pantoprazole on the efficacy of calcium carbonate as a phosphate binder in haemodialysis patients.

Authors:  Matthew J Cervelli; Ahmed Shaman; Anthony Meade; Robert Carroll; Stephen P McDonald
Journal:  Nephrology (Carlton)       Date:  2012-07       Impact factor: 2.506

3.  Proton-pump inhibitors for prevention of upper gastrointestinal bleeding in patients undergoing dialysis.

Authors:  Young Rim Song; Hyung Jik Kim; Jwa-Kyung Kim; Sung Gyun Kim; Sung Eun Kim
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

4.  Prevalence of gastroesophageal reflux disease symptoms and effects of esomeprazole on the quality of life related to reflux and dyspepsia in patients on maintenance hemodialysis.

Authors:  Tamehachi Namikoshi; Kazuhiro Harada; Hidekazu Hatta; Takehiko Tokura; Yoshiyuki Oshiro; Tetsuichi Nishizaki; Takahiro Obata; Masahiro Mori; Takaaki Fueki; Sohachi Fujimoto; Yoshisuke Haruna; Atsunori Kuwabara; Daisuke Yorimitsu; Chieko Ihoriya; Hiroyuki Kadoya; Seiji Itano; Yasuo Fujimoto; Norio Komai; Tamaki Sasaki; Naoki Kashihara
Journal:  Clin Exp Nephrol       Date:  2015-05-31       Impact factor: 2.801

5.  Proton Pump Inhibitor Use and Risk of Hip Fracture in Kidney Transplant Recipients.

Authors:  Colin R Lenihan; Sumi Sukumaran Nair; Chandan Vangala; Venkat Ramanathan; Maria E Montez-Rath; Wolfgang C Winkelmayer
Journal:  Am J Kidney Dis       Date:  2016-11-17       Impact factor: 8.860

6.  Prophylactic use of omeprazole associated with a reduced risk of peptic ulcer disease among maintenance hemodialysis patients.

Authors:  Chih-Chia Liang; I-Kuan Wang; Hsin-Hung Lin; Hung-Chieh Yeh; Jiung-Hsiun Liu; Huey-Liang Kuo; Wei-Min Hsu; Chiu-Ching Huang; Chiz-Tzung Chang
Journal:  Ren Fail       Date:  2011       Impact factor: 2.606

7.  Long-term proton pump inhibitor use is associated with vascular calcification in chronic kidney disease: a cross-sectional study using propensity score analysis.

Authors:  Maria Fusaro; Marianna Noale; Giovanni Tripepi; Sandro Giannini; Angela D'Angelo; Angelo Pica; Lorenzo A Calò; Davide Miozzo; Maurizio Gallieni
Journal:  Drug Saf       Date:  2013-08       Impact factor: 5.606

8.  US Renal Data System 2017 Annual Data Report: Epidemiology of Kidney Disease in the United States.

Authors:  Rajiv Saran; Bruce Robinson; Kevin C Abbott; Lawrence Y C Agodoa; Nicole Bhave; Jennifer Bragg-Gresham; Rajesh Balkrishnan; Xue Dietrich; Ashley Eckard; Paul W Eggers; Abduzhappar Gaipov; Daniel Gillen; Debbie Gipson; Susan M Hailpern; Yoshio N Hall; Yun Han; Kevin He; William Herman; Michael Heung; Richard A Hirth; David Hutton; Steven J Jacobsen; Yan Jin; Kamyar Kalantar-Zadeh; Alissa Kapke; Csaba P Kovesdy; Danielle Lavallee; Janet Leslie; Keith McCullough; Zubin Modi; Miklos Z Molnar; Maria Montez-Rath; Hamid Moradi; Hal Morgenstern; Purna Mukhopadhyay; Brahmajee Nallamothu; Danh V Nguyen; Keith C Norris; Ann M O'Hare; Yoshitsugu Obi; Christina Park; Jeffrey Pearson; Ronald Pisoni; Praveen K Potukuchi; Panduranga Rao; Kaitlyn Repeck; Connie M Rhee; Jillian Schrager; Douglas E Schaubel; David T Selewski; Sally F Shaw; Jiaxiao M Shi; Monica Shieu; John J Sim; Melissa Soohoo; Diane Steffick; Elani Streja; Keiichi Sumida; Manjula K Tamura; Anca Tilea; Lan Tong; Dongyu Wang; Mia Wang; Kenneth J Woodside; Xin Xin; Maggie Yin; Amy S You; Hui Zhou; Vahakn Shahinian
Journal:  Am J Kidney Dis       Date:  2018-03       Impact factor: 8.860

9.  Proton pump inhibitor omeprazole use is associated with low bone mineral density in maintenance haemodialysis patients.

Authors:  A Kirkpantur; B Altun; M Arici; C Turgan
Journal:  Int J Clin Pract       Date:  2009-02       Impact factor: 2.503

10.  Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study.

Authors:  Hamed Khalili; Edward S Huang; Brian C Jacobson; Carlos A Camargo; Diane Feskanich; Andrew T Chan
Journal:  BMJ       Date:  2012-01-30
View more
  2 in total

Review 1.  Iron Therapy in Chronic Kidney Disease: Days of Future Past.

Authors:  Kuo-Hua Lee; Yang Ho; Der-Cherng Tarng
Journal:  Int J Mol Sci       Date:  2021-01-20       Impact factor: 5.923

2.  Prognostic impact of polypharmacy by drug essentiality in patients on hemodialysis.

Authors:  Mineaki Kitamura; Kosei Yamaguchi; Yuki Ota; Satoko Notomi; Maya Komine; Rika Etoh; Takashi Harada; Satoshi Funakoshi; Hiroshi Mukae; Tomoya Nishino
Journal:  Sci Rep       Date:  2021-12-20       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.